title: Multidisciplinary approach to brain metastasis from melanoma; local therapies for central nervous system metastases.
abstract: The overall treatment paradigm for melanoma brain metastases continues to evolve and reflects the relative radioresistance of this histology, as well as the effect of emerging systemic therapies with central nervous system (CNS) activity. Local therapies, including surgery, whole brain radiotherapy (WBRT), and stereotactic radiosurgery (SRS), play an important role in the multidisciplinary management of melanoma brain metastases. Treatment selection for local therapies must consider many factors: (1) size, number, and location of lesions, (2) presence or absence of neurological symptoms, (3) extracranial disease status, expected survival, age, and performance status, (4) prior treatment history, (5) expected treatment toxicities, and (6) predicted response to systemic therapies. The choice of treatment modalities for brain metastases is among the most controversial areas in oncology. There has been a trend toward reduced use of WBRT and increased reliance on SRS and surgery for melanoma brain metastases. Although no prospective randomized data exist comparing local therapies for melanoma brain metastases, several large retrospective studies suggest aggressive local treatment with modalities including surgery and SRS are associated with favorable outcomes in select patients. Multidisciplinary collaboration is required to facilitate a treatment plan that balances reduction in risk of neurological death and symptomatic progression against the risk of treatment-related toxicity.
authors.affiliation: From the MD Anderson Cancer Center Orlando, University of Central Florida College of Medicine, Orlando FL; University of Washington Fred Hutchinson Cancer Research Center, Seattle, WA.
authors.forename: Naren
authors.initials: N
authors.lastname: Ramakrishna
authors.forename: Kim A
authors.initials: KA
authors.lastname: Margolin
mesh_terms: D001921:Brain / Q000473:pathology / Q000528:radiation effects; D001932:Brain Neoplasms / Q000453:epidemiology / Q000532:radiotherapy / Q000556:secondary* / Q000601:surgery; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D016371:Cranial Irradiation / Q000009:adverse effects; D003399:Craniotomy; D018450:Disease Progression; D006801:Humans; D033183:Interdisciplinary Communication; D008545:Melanoma / Q000453:epidemiology / Q000532:radiotherapy / Q000556:secondary* / Q000601:surgery; D009336:Necrosis; D010348:Patient Care Team; D011832:Radiation Injuries / Q000209:etiology / Q000473:pathology / Q000517:prevention & control; D016634:Radiosurgery / Q000009:adverse effects; D016896:Treatment Outcome